ValenzaBio is Drug Discovery in United States that focus on developer business. Founded in 2019. They cover business area such as developer, antibody therapy, safe and effective treatment option, patient, unmet need, several monoclonal antibody, surface antigen, pathogenic subpopulation, autoreactive cell, researcher, new treatment option, autoimmune and inflammatory disease.
2019
( 7 years old in 2026 )
Developer
-
6701 Democracy Boulevard
Suite 300
Bethesda, MD 20817
United States
Private
developerantibody therapysafe and effective treatment optionpatientunmet needseveral monoclonal antibodysurface antigenpathogenic subpopulationautoreactive cellresearchernew treatment optionautoimmune and inflammatory disease
* We use standard office opening hours in near ValenzaBio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ValenzaBio is Drug Discovery business from United States that founded in 2019 (7 years old in 2026), ValenzaBio business is focusing on Developer.
ValenzaBio headquarter office and corporate office address is located in 6701 Democracy Boulevard Suite 300 Bethesda, MD 20817 United States.
ValenzaBio was founded in United States.
In 2026, ValenzaBio is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ValenzaBio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
